Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Ammonium
12%
AS101
100%
Autocrine Growth Factors
100%
Cancer Patients
12%
Cellular Factors
12%
Clonogenicity
12%
Cyclin D1 (CCND1)
12%
Cyclin E
12%
Cyclin-dependent Kinase 2 (CDK2)
12%
Cyclin-dependent Kinase 4 (CDK4)
12%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
12%
Disease-associated
12%
Downstream Targets
25%
Glial Cell Line-derived Neurotrophic Factor
100%
Glomerular Disease
37%
Hyperphosphorylation
12%
Hyperplasia
12%
Immunomodulator
100%
In Vivo Animal Studies
12%
Interleukin-10
100%
Mesangial Cell Proliferation
50%
Mesangial Cells
50%
Mesangium
100%
Mitogenesis
12%
Negatively Regulate
12%
Neurotrophic Factors Expression
12%
NF-B
12%
P27Kip1
12%
Phase I Trial
12%
Phase Progression
12%
Phosphatidylinositol 3-kinase Pathway
12%
Proliferation in Vitro
12%
Rat Mesangial Cells
12%
Retinoblastoma
12%
Tellurate
12%
Tellurium
12%
Therapeutic Interventions
12%
Pharmacology, Toxicology and Pharmaceutical Science
9 [(4 Acetyl 3 Hydroxy 2 Propylphenoxy)methyl] 3 (1h Tetrazol 5 Yl) 4h pyrido[1,2 A]pyrimidin 4 One
12%
Ammonium Trichloro(dioxyethylene O,o')tellurate
100%
Cell Hyperplasia
12%
Clinical Trial
12%
Cyclin D1
12%
Cyclin Dependent Kinase Inhibitor
12%
Cyclin E
12%
Diseases
37%
Glial Cell Line Derived Neurotrophic Factor
100%
Growth Factor
100%
Immunomodulating Agent
100%
Interleukin 10
100%
Malignant Neoplasm
12%
Neurotrophic Factor Expression
12%
Pathogenesis
12%
Phosphatidylinositol 3 Kinase
12%
Rat
12%
Retinoblastoma
12%
Biochemistry, Genetics and Molecular Biology
Neurotrophic Factor Expression
12%